Post by cjm on Oct 7, 2015 8:52:17 GMT
Now the Communists are after patents again.
...
The Department of Trade and Industry (DTI) has found a new way to weaken patent rights via the Copyright Amendment Bill of 2015 (the Copyright Bill) and its proposed new “intellectual property tribunal” (the IP tribunal).
....
www.biznews.com/thought-leaders/2015/10/07/anthea-jeffery-copyright-bill-unconstitutional-should-be-withdrawn/
Perhaps the following report should already be read in conjunction.
www.dailymaverick.co.za/article/2015-10-05-groundup-sole-supplier-axes-life-saving-drug/
...
South Africa is running out of an essential medicine for treating very sick patients with tuberculosis (TB) and drug-resistant bacterial infections. Many hospitals are already out of stock.
Intravenous Rifampicin is used to treat patients who are very sick and usually in intensive care. It is an essential medicine for treating TB. Normally, patients take it as a pill (and there is no shortage of the drug in this form). However, a small number of patients are so ill that they cannot take pills, and the drug has to be administered intravenously.
Marian Gray-Wilson, the customer service officer for Sandoz, the only company selling the drug in South Africa, sent a letter addressed to “valued customers” on 9 September stating that the drug is being “discontinued”. “We apologise for any inconvenience caused due to this product discontinuation,” the letter said. Sandoz is a subsidiary of the Swiss-based multinational pharmaceutical company Novartis.
...
...
The Department of Trade and Industry (DTI) has found a new way to weaken patent rights via the Copyright Amendment Bill of 2015 (the Copyright Bill) and its proposed new “intellectual property tribunal” (the IP tribunal).
....
www.biznews.com/thought-leaders/2015/10/07/anthea-jeffery-copyright-bill-unconstitutional-should-be-withdrawn/
Perhaps the following report should already be read in conjunction.
www.dailymaverick.co.za/article/2015-10-05-groundup-sole-supplier-axes-life-saving-drug/
...
South Africa is running out of an essential medicine for treating very sick patients with tuberculosis (TB) and drug-resistant bacterial infections. Many hospitals are already out of stock.
Intravenous Rifampicin is used to treat patients who are very sick and usually in intensive care. It is an essential medicine for treating TB. Normally, patients take it as a pill (and there is no shortage of the drug in this form). However, a small number of patients are so ill that they cannot take pills, and the drug has to be administered intravenously.
Marian Gray-Wilson, the customer service officer for Sandoz, the only company selling the drug in South Africa, sent a letter addressed to “valued customers” on 9 September stating that the drug is being “discontinued”. “We apologise for any inconvenience caused due to this product discontinuation,” the letter said. Sandoz is a subsidiary of the Swiss-based multinational pharmaceutical company Novartis.
...